Overview

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

Status:
Not yet recruiting
Trial end date:
2022-08-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Xylitol plus Grapefruit Seed Extract (Xlear) nasal spray as an adjunct treatment of COVID-19.
Phase:
Phase 3
Details
Lead Sponsor:
Larkin Community Hospital
Collaborators:
Ferrer Medical Innovations
Xlear